Home / Meningococcus B, Multicomponent Vaccine / Austria
AT ATC J07AH09 · updated 2 Nov 2026
Meningococcus B, Multicomponent Vaccine shortage in Austria
Is there a Meningococcus B, Multicomponent Vaccine shortage in Austria?
Yes. As of 2 Nov 2026, 1 Meningococcus B, Multicomponent Vaccine product is reported short in Austria, the first since 27 Aug 2026. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Bexsero Injektionssuspension in Fertigspritze Impfstoff gegen Meningokokken der Gruppe B (rDNA, Komponenten, adsorbiert), 1 Stück limited | Glaxosmithkline Vaccines S.r.l. | 27 Aug 2026 | 31 Dec 2026 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).